The Effectiveness of Pharmacological Agents for the Treatment of Uveitic Macular Edema (UMO): A Systematic Review

Purpose: To conduct a systematic review of effectiveness of pharmacological therapies for treatment of Uveitic Macular Edema (UMO). Method/Design: Comparative studies of pharmacological therapies in patients with UMO were identified in Cochrane CENTRAL/MEDLINE/EMBASE/CINAHL/trials registers (Februar...

Full description

Saved in:
Bibliographic Details
Published in:Ocular immunology and inflammation 2019-05, Vol.27 (4), p.658-680
Main Authors: Tallouzi, Mohammad O., Moore, David J., Barry, Robert J., Calvert, Melanie, Mathers, Jonathan, Murray, Philip I., Denniston, Alastair K.
Format: Article
Language:English
Subjects:
Anti-Inflammatory Agents, Non-Steroidal - pharmacology
Glucocorticoids - therapeutic use
Humans
Macular edema
Macular Edema - drug therapy
Macular Edema - etiology
management
meta-analysis
pharmacological agents
systematic review
treatment
Treatment Outcome
uveitis
Uveitis - complications
Uveitis - drug therapy
Visual Acuity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: To conduct a systematic review of effectiveness of pharmacological therapies for treatment of Uveitic Macular Edema (UMO). Method/Design: Comparative studies of pharmacological therapies in patients with UMO were identified in Cochrane CENTRAL/MEDLINE/EMBASE/CINAHL/trials registers (February 2017). PROSPERO registration: CRD42015019170. Results: Thirty-one studies were included. Corticosteroids were the most frequently studied (n = 20). Corticosteroids (all forms) were consistently of greater/equal efficacy to active comparators; for anti-VEGF (n = 4) improvement, best-corrected visual acuity (BCVA) and central macular thickness (CMT) were mostly less than local corticosteroid injection; for interferon (n = 1) improvement BCVA and CMT were greater than the comparator of methotrexate; for topical indomethacin (n = 1) improvement, BCVA and CMT were greater than placebo. Non-steroidal anti-inflammatory drugs, carbonic anhydrase inhibitors, and vitamin E (n = 5) were not effective for these outcomes. Conclusion: The review highlights areas where the evidence base is still lacking, and appropriately focused trials are needed to inform best treatment to tackle this sight-threatening condition.
ISSN:0927-3948
1744-5078
DOI:10.1080/09273948.2019.1569243